合生元
肠道菌群
医学
肥胖
益生菌
生理学
生物
内科学
免疫学
细菌
遗传学
作者
Hangyu Li,Dan-Dan Zhou,Ren‐You Gan,Siyu Huang,Cong Zhao,Ao Shang,Xiaoyu Xu,Hua-Bin Li
出处
期刊:Nutrients
[MDPI AG]
日期:2021-09-15
卷期号:13 (9): 3211-3211
被引量:101
摘要
Metabolic diseases are serious threats to public health and related to gut microbiota. Probiotics, prebiotics, synbiotics, and postbiotics (PPSP) are powerful regulators of gut microbiota, thus possessing prospects for preventing metabolic diseases. Therefore, the effects and mechanisms of PPSP on metabolic diseases targeting gut microbiota are worth discussing and clarifying. Generally, PPSP benefit metabolic diseases management, especially obesity and type 2 diabetes mellitus. The underlying gut microbial-related mechanisms are mainly the modulation of gut microbiota composition, regulation of gut microbial metabolites, and improvement of intestinal barrier function. Moreover, clinical trials showed the benefits of PPSP on patients with metabolic diseases, while the clinical strategies for gestational diabetes mellitus, optimal formula of synbiotics and health benefits of postbiotics need further study. This review fully summarizes the relationship between probiotics, prebiotics, synbiotics, postbiotics, and metabolic diseases, presents promising results and the one in dispute, and especially attention is paid to illustrates potential mechanisms and clinical effects, which could contribute to the next research and development of PPSP.
科研通智能强力驱动
Strongly Powered by AbleSci AI